Cargando…
Erythropoietin inhibits chemotherapy-induced cell death and promotes a senescence-like state in leukemia cells
There are conflicting reports on the adverse effects of erythropoietin (EPO) for the management of cancer-associated anemia. The recognition that erythropoietin receptors (EPORs) are expressed outside the erythroid lineage and concerns that erythropoiesis-stimulating agents (ESAs) may cause tumors t...
Autores principales: | Pham, Thuc-Nghi Duc, Ma, Weili, Miller, David, Kazakova, Lidia, Benchimol, Samuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325163/ https://www.ncbi.nlm.nih.gov/pubmed/30622244 http://dx.doi.org/10.1038/s41419-018-1274-6 |
Ejemplares similares
-
Heterogeneity in leukemia cells that escape drug-induced senescence-like state
por: Miller, David, et al.
Publicado: (2023) -
Cell death and senescence
por: Galluzzi, Lorenzo, et al.
Publicado: (2023) -
Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe
por: Pérès, Elodie A., et al.
Publicado: (2014) -
Markers of T Cell Senescence in Humans
por: Xu, Weili, et al.
Publicado: (2017) -
Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro
por: Våtsveen, Thea Kristin, et al.
Publicado: (2016)